Abstract
Problems with infection of a total hip replacement (THR) derive from the presence of biofilms with inherent resistance to usual antibiotic treatment and bone defects resulting from infection-induced osteolysis. Discussions on the choice of treatment mainly focus on the chance of eradicating the infection in either one or more stages. The advantages of only one operation regarding patients’ satisfaction, functional results and economical burden are evident. However, the fear of re-infection usually leads surgeons to multiple-stage procedures, mostly using antibiotic-loaded spacers in the interval. Antibiotic concentrations eluted from spacers have no effect on biofilms and might be associated with a high rate of complications like breakage or dislocation.
One-stage revisions so far were mostly with cemented prostheses admixing antibiotics to the cement. Cemented revisions show several disadvantages: the addition of antibiotics to cement reduces its biomechanical properties with inferior long-term results compared to uncemented techniques. Efficient cementing techniques result in tight bonding with the underlying bone, making eventual removal time-consuming and possibly associated with further damage to the osseous structures. Uncemented implants appear more advantageous but are at risk of becoming colonized by eventually remaining biofilm fragments, requiring local application of antibiotics. Uncemented prostheses can be removed as easily as spacers in case of failure and may be left in place in case of success.
Allograft bone may be impregnated with high loads of antibiotics using special impregnation techniques, resulting in an antibiotic bone compound (ABC). ABC provides local concentrations exceeding those of cement by more than a 100-fold and efficient release is prolonged for several weeks. The same time it is most likely to restore bone stock, which usually is compromised after removal of an infected endoprosthesis. Effective local antimicrobial concentrations in combination with radical debridement may be suitable for eradicating infection with a single operation in the majority of cases.
Based on these considerations a new protocol for one-stage exchange of infected TJR has been established in our institution. Bone defects are filled with ABC, uncemented implants are fixed in original healthy bone. With ABC, providing a sustained antibiotic release with biofilm-active concentrations, microscopical remnants of biofilm may be eliminated. Results indicate an overall success rate of more than 90 % with one operation, without any adverse side effects. Incorporation of allografts appears as after grafting with unimpregnated bone, in the radiographic follow-up. One-stage revision using ABC together with uncemented implants should be at least comparably safe as multiple-stage procedures, offering clear advantages for the quality of life of patients as well as from economic standpoints.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kuiper JW, Vos SJ, Saouti R, Vergroesen DA, Graat HC, Debets-Ossenkopp YJ, et al. Prosthetic joint-associated infections treated with DAIR (debridement, antibiotics, irrigation, and retention): analysis of risk factors and local antibiotic carriers in 91 patients. Acta Orthop. 2013;84(4):380–6.
Beswick AD, Elvers KT, Smith AJ, Gooberman-Hill R, Lovering A, Blom AW. What is the evidence base to guide surgical treatment of infected hip prostheses? systematic review of longitudinal studies in unselected patients. BMC Med. 2012;10:18 [Meta-Analysis Research Support, Non-U.S. Gov’t Review].
McKenna PB, O’Shea K, Masterson EL. Two-stage revision of infected hip arthroplasty using a shortened post-operative course of antibiotics. Arch Orthop Trauma Surg. 2008;129:489–94.
Puhto AP, Puhto T, Syrjala H. Short-course antibiotics for prosthetic joint infections treated with prosthesis retention. Clin Microbiol Infect. 2012;18(11):1143–8.
Bozic KJ, Ries MD. The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization. J Bone Joint Surg Am. 2005;87(8):1746–51.
Wolf CF, Gu NY, Doctor JN, Manner PA, Leopold SS. Comparison of one and two-stage revision of total hip arthroplasty complicated by infection: a Markov expected-utility decision analysis. J Bone Joint Surg Am. 2011;93(7):631–9.
Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284(5418):1318–22.
Gristina AG, Costerton JW. Bacterial adherence to biomaterials and tissue. The significance of its role in clinical sepsis. J Bone Joint Surg Am. 1985;67(2):264–73.
Costerton JW. Biofilm theory can guide the treatment of device-related orthopaedic infections. Clin Orthop Relat Res. 2005;437:7–11.
Saginur R, Stdenis M, Ferris W, Aaron SD, Chan F, Lee C, et al. Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections. Antimicrob Agents Chemother. 2006;50(1):55–61.
van de Belt H, Neut D, Schenk W, van Horn JR, van der Mei HC, Busscher HJ. Infection of orthopedic implants and the use of antibiotic-loaded bone cements. A review. Acta Orthop Scand. 2001;72(6):557–71.
Lie SA, Havelin LI, Furnes ON, Engesaeter LB, Vollset SE. Failure rates for 4762 revision total hip arthroplasties in the Norwegian Arthroplasty Register. J Bone Joint Surg Br. 2004;86(4):504–9.
Cabo J, Euba G, Saborido A, Gonzalez-Panisello M, Dominguez MA, Agullo JL, et al. Clinical outcome and microbiological findings using antibiotic-loaded spacers in two-stage revision of prosthetic joint infections. J Infect. 2011;67:82–4.
Nelson CL, Jones RB, Wingert NC, Foltzer M, Bowen TR. Sonication of antibiotic spacers predicts failure during two-stage revision for prosthetic knee and hip infections. Clin Orthop Relat Res. 2014;472(7):2208–14.
Sorli L, Puig L, Torres-Claramunt R, Gonzalez A, Alier A, Knobel H, et al. The relationship between microbiology results in the second of a two-stage exchange procedure using cement spacers and the outcome after revision total joint replacement for infection: the use of sonication to aid bacteriological analysis. J Bone Joint Surg Br. 2012;94(2):249–53.
Neut D, van De Belt H, Stokroos I, van Horn JR, van Der Mei HC, Busscher HJ. Biomaterial-associated infection of gentamicin-loaded PMMA beads in orthopaedic revision surgery. J Antimicrob Chemother. 2001;47(6):885–91.
Buchholz HW, Engelbrecht H. Depot effects of various antibiotics mixed with Palacos resins. Chirurg. 1970;41(11):511–5.
Gehrke T, Zahar A, Kendoff D. One-stage exchange: it all began here. Bone Joint J. 2013;95-B(11 Supple A):77–83.
Edin ML, Miclau T, Lester GE, Lindsey RW, Dahners LE. Effect of cefazolin and vancomycin on osteoblasts in vitro. Clin Orthop Relat Res. 1996;333:245–51.
Buttaro MA, Gimenez MI, Greco G, Barcan L, Piccaluga F. High active local levels of vancomycin without nephrotoxicity released from impacted bone allografts in 20 revision hip arthroplasties. Acta Orthop. 2005;76(3):336–40.
Hazlett JW. The use of cancellous bone grafts in the treatment of subacute and chronic osteomyelitis. J Bone Joint Surg Br. 1954;36-B(4):584–90.
Ammon P, Stockley I. Allograft bone in two-stage revision of the hip for infection. Is it safe? J Bone Joint Surg Br. 2004;86(7):962–5.
Hsieh PH, Shih CH, Chang YH, Lee MS, Yang WE, Shih HN. Treatment of deep infection of the hip associated with massive bone loss: two-stage revision with an antibiotic-loaded interim cement prosthesis followed by reconstruction with allograft. J Bone Joint Surg Br. 2005;87-B(6):770–5.
Buttaro MA, Pusso R, Piccaluga F. Vancomycin-supplemented impacted bone allografts in infected hip arthroplasty. Two-stage revision results. J Bone Joint Surg Br. 2005;87(3):314–9.
Winkler H, Janata O, Berger C, Wein W, Georgopoulos A. In vitro release of vancomycin and tobramycin from impregnated human and bovine bone grafts. J Antimicrob Chemother. 2000;46(3):423–8.
Fages J, Marty A, Delga C, Condoret JS, Combes D, Frayssinet P. Use of supercritical CO2 for bone delipidation. Biomaterials. 1994;15(9):650–6.
Fages J, Poirier B, Barbier Y, Frayssinet P, Joffret ML, Majewski W, et al. Viral inactivation of human bone tissue using supercritical fluid extraction. ASAIO J. 1998;44(4):289–93.
Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med. 2004;351(16):1645–54.
Ibrahim MS, Raja S, Haddad FS. Acetabular impaction bone grafting in total hip replacement. Bone Joint J. 2013;95-B(11 Suppl A):98–102 [Review].
Paprosky WG, Perona PG, Lawrence JM. Acetabular defect classification and surgical reconstruction in revision arthroplasty. A 6-year follow-up evaluation. J Arthroplasty. 1994;9(1):33–44.
Winkler H, Stoiber A, Kaudela K, Winter F, Menschik F. One stage uncemented revision of infected total hip replacement using cancellous allograft bone impregnated with antibiotics. J Bone Joint Surg Br. 2008;90-B(12):1580–4.
Trampuz A, Piper KE, Jacobson MJ, Hanssen AD, Unni KK, Osmon DR, et al. Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med. 2007;357(7):654–63.
Winkler H, Kaudela K, Stoiber A, Menschik F. Bone grafts impregnated with antibiotics as a tool for treating infected implants in orthopedic surgery – one stage revision results. Cell Tissue Bank. 2006;7(4):319–23.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Winkler, H., Haiden, P. (2016). Infections of the Hip Joint: One-Stage Approach Without Cement. In: Kendoff, D., Morgan-Jones, R., Haddad, F. (eds) Periprosthetic Joint Infections. Springer, Cham. https://doi.org/10.1007/978-3-319-30091-7_13
Download citation
DOI: https://doi.org/10.1007/978-3-319-30091-7_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-30089-4
Online ISBN: 978-3-319-30091-7
eBook Packages: MedicineMedicine (R0)